CTI BioPharma Corp. Profile Avatar - Palmy Investing

CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…

Biotechnology
US, Seattle [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of CTIC's Analysis
CIK: 891293 CUSIP: 12648L601 ISIN: US12648L6011 LEI: - UEI: -
Secondary Listings
CTIC has no secondary listings inside our databases.